Evaluation of the national health policy of thalassaemia screening the Islamic Republic of Iran

Eastern Mediterranean Health Journal

Volumn 11, Issue 3, 2005, Pages 308-318

  Ghotbi, N ^a   Tsukatani, T ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHORION VILLUS SAMPLING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; FEMALE; FOLLOW UP; GENETIC COUNSELING; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; INTERVIEW; IRAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MASS SCREENING; POPULATION DISTRIBUTION; PRENATAL DIAGNOSIS; PUBLIC HEALTH SERVICE; SOUTHERN EUROPE; THALASSEMIA MAJOR;

AFTERCARE; AGE DISTRIBUTION; BETA-THALASSEMIA; CHILD; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DECISION TREES; EFFICIENCY, ORGANIZATIONAL; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HEALTH POLICY; HEALTH SERVICES NEEDS AND DEMAND; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; IRAN; MALE; NATIONAL HEALTH PROGRAMS; PREVALENCE; PROGRAM EVALUATION; REFERRAL AND CONSULTATION; REGISTRIES; SEX DISTRIBUTION;

EID: 33645310167     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization, 2001, 79(8):704-12.
2. Indaratna K. Screening for thalassemia: an economics viewpoint. Southeast Asian journal of tropical medicine and public health, 1997, 28(suppl. 3):75-81.
3. Mitchell JJ et al. Twenty-year outcome analysis of genetic screening programmes for Tay-Sachs and beta-thalassaemia disease carriers in high schools. American journal of human genetics, 1996, 59(4):793-8.
4. Altay C et al. Premarital screening of hemoglobinopathies: a pilot study in Turkey. Human heredity, 1996, 46(2):112-4.
5. Curuk MA et al. Genetic heterogeneity of beta-thalassaemia at Cukurova in southern Turkey. Hemoglobin, 2001, 25(2): 241-5.
6. Keskin A et al. Premarital screening of beta-thalassaemia trait in the province of Denizli, Turkey. Acta haematologica, 2000, 104(1):31-3.
7. Khan SN, Riazuddin S. Molecular characterization of beta-thalassaemia in Pakistan. Hemoglobin, 1998, 22(4): 333-45.
8. Emadi A, Koorosdari H, Pakbaz Z. Thalassaemia. Mass screening of beta thalassaemia minor in high school students of Tehran (1995-1996). Biannual journal of Iran. Thalassemic Patients Supporting Society, 1997, vol. 12 (in Persian with English abstract).
9. Scriver CR et al. Beta thalassaemia disease prevention: genetic medicine applied. American journal of human genetics, 1984, 36:1024.
10. Hendy J. Prevention of thalassaemia in Australia. Southeast Asian journal of tropical medicine and public health, 1999, 30(suppl. 2):94-6.
11. Ko TM, Xu X. Molecular study and prenatal diagnosis of alpha- and beta-thalassaemias in Chinese. Journal of the Formosan Medical Association, 1998, 97(1):5-15.
12. Lee AC et al. Prevention of beta-thatassaemia major by antenatal screening in Hong Kong. Pediatric haematology and oncology, 1998, 15(3): 249-54.
13. Yong KN et al. Thalassaemia carrier screening and prenatal diagnosis among the British Columbia (Canada) population of Chinese descent. Clinical genetics, 1999, 55(1):20-5.
14. Altay C et al. Premarital screening of hemoglobinopathies: a pilot study in Turkey. Human heredity, 1996, 46(2):112-4.
15. Jaovisidha A et al. Prevention and control of thalassaemia in Ramathibodi Hospital, Thailand. Southeast Asian journal of tropical medicine and public health, 2000, 31(3):561-5.
16. Thool AA et al. A simple screening test for the detection of heterozygous beta thalassaemia. Indian journal of pathology and microbiology, 1998, 41(4):423-6.
17. Gomber S, Sajeev, Madan N. Validity of Nestroft in screening and diagnosis of beta-thalassaemia trait. Journal of tropical pediatrics, 1997, 43(6):363-6.
18. Manglani M et al. NESTROFT: an effective screening test for beta thalassaemia trait. Indian pediatrics, 1997, 34(8):702-7.
19. Karimi M, Alavian Ghavanini A, Kadivar MR. Regional mapping of the gene frequency of beta thalassaemia in Fars province, Iran during 1997-1998. Iranian journal of medical sciences, 2000, 25(3-4):134-7.
20. Ghanei M et al. Pre-marriage prevention of thalassaemia: report of a 100 000 case experience in Isfahan. Public health, 1997, 111(3):153-6.
21. Christianson A, Streetly A, Darr A. Lessons from thalassaemia screening in Iran. British medical journal, 2004, 329(7475):1115-7.
22. Angastiniotis MA, Hadjiminas MG. Prevention of thalassaemia in Cyprus. Lancet, 1981, 1:369-71.
23. Karnon J et al. Lifetime treatment costs of beta-thalassaemia major. Clinical and laboratory haematology, 1999, 21(6): 377-85.
24. Alwan A, Modell B. Community control of genetic and congenital disorders. Alexandria, World Health Organization, Regional Office for the Eastern Mediterranean, 1997.
25. Alwan A, Modell B. Recommendations for introducing genetics services in developing countries. Nature reviews. Genetics, 2003 4(1):61-8.
26. Samavat A, Modell B. Iranian national thalassaemia screening programme. British medical journal, 2004, 329: 1134-7.
27. Cao A et al. The prenatal diagnosis of thalassaemia. British journal of haematology, 1986, 63:215.
28. Vullo C, Barry F. Population screening for carriers of recessively inherited disorders. Lancet, 1980, 2(8196):679-80.
29. Iran - second primary health care and nutrition project. Washington, World Bank, 2001 (Report number PID8574) Available at: http://www-wds.worldbank.org/servlet/WDSContentServer/WDSP/IB/2000/03/21/ 000094946_00031505340433/Rendered/PDF/multi0page.pdf (accessed: 11/4/05).
30. Sirdah M et al. Screening secondary school students in the Gaza strip for beta-thalassaemia trait. Clinical and laboratory hematology, 1998, 20(5): 279-83.
31. Najmabadi H et al. The beta thalassaemia mutation spectrum in the Iranian population. Hemoglobin, 2001, 25(3): 285-96.
32. Yavarian M et al. Molecular spectrum of beta-thalassaemia in the Iranian Province of Hormozgan. Hemoglobin, 2001, 25(1):35-43.